Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 32 entries
Sorted by: Best Match Show Resources per page
Antihistamines and itching.

Medicina espanola

LOPEZ-BOTET E, RUIPEREZ PEREZ JA.
PMID: 18102017
Med Esp. 1948 Sep;11(114):179-85.

No abstract available.

Cite
LOPEZ-BOTET E, RUIPEREZ PEREZ JA. Antihistamänicos y prurito. Antihistamines and itching. Med Esp. 1948;11(114):179-85
LOPEZ-BOTET, E., & RUIPEREZ PEREZ, J. A. (1948). Antihistamänicos y prurito. Antihistamines and itching. Medicina espanola, 11(114), 179-85.
LOPEZ-BOTET, E, and RUIPEREZ PEREZ, J A. "Antihistamänicos y prurito." Antihistamines and itching. Medicina espanola vol. 11,114 (1948): 179-85.
LOPEZ-BOTET E, RUIPEREZ PEREZ JA. Antihistamänicos y prurito. Antihistamines and itching. Med Esp. 1948 Sep;11(114):179-85. Spanish. PMID: 18102017.
Copy Download .nbib Format: NLM
Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus.

Frontiers in immunology

Muntasell A, Costa-Garcia M, Vera A, Marina-Garcia N, Kirschning CJ, López-Botet M.
PMID: 23440148
Front Immunol. 2013 Feb 21;4:40. doi: 10.3389/fimmu.2013.00040. eCollection 2013.

Natural killer (NK) cells play an important role in the defense against viral infections. Activation of resting NK cells is tightly controlled by the balance of surface inhibitory and activating receptors and aided by cytokines released by accessory cells...

Cite
Muntasell A, Costa-Garcia M, Vera A, et al. Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus. Front Immunol. 2013;4:40doi: 10.3389/fimmu.2013.00040.
Muntasell, A., Costa-Garcia, M., Vera, A., Marina-Garcia, N., Kirschning, C. J., & López-Botet, M. (2013). Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus. Frontiers in immunology, 440. https://doi.org/10.3389/fimmu.2013.00040
Muntasell, Aura, et al. "Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus." Frontiers in immunology vol. 4 (2013): 40. doi: https://doi.org/10.3389/fimmu.2013.00040
Muntasell A, Costa-Garcia M, Vera A, Marina-Garcia N, Kirschning CJ, López-Botet M. Priming of NK cell anti-viral effector mechanisms by direct recognition of human cytomegalovirus. Front Immunol. 2013 Feb 21;4:40. doi: 10.3389/fimmu.2013.00040. eCollection 2013. PMID: 23440148; PMCID: PMC3578278.
Copy Download .nbib Format: NLM
KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression.

Frontiers in immunology

Cisneros E, Moraru M, Gómez-Lozano N, López-Botet M, Vilches C.
PMID: 23060877
Front Immunol. 2012 Sep 17;3:289. doi: 10.3389/fimmu.2012.00289. eCollection 2012.

A recently developed anti-KIR2DL5 (CD158f) antibody has demonstrated KIR2DL5 expression on the surface of NK and T lymphocytes, making it the last functional KIR identified in the human genome. KIR2DL5 belongs to an ancestral lineage of KIR with Ig-like...

Cite
Cisneros E, Moraru M, Gómez-Lozano N, et al. KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression. Front Immunol. 2012;3:289doi: 10.3389/fimmu.2012.00289.
Cisneros, E., Moraru, M., Gómez-Lozano, N., López-Botet, M., & Vilches, C. (2012). KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression. Frontiers in immunology, 3289. https://doi.org/10.3389/fimmu.2012.00289
Cisneros, Elisa, et al. "KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression." Frontiers in immunology vol. 3 (2012): 289. doi: https://doi.org/10.3389/fimmu.2012.00289
Cisneros E, Moraru M, Gómez-Lozano N, López-Botet M, Vilches C. KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression. Front Immunol. 2012 Sep 17;3:289. doi: 10.3389/fimmu.2012.00289. eCollection 2012. PMID: 23060877; PMCID: PMC3443818.
Copy Download .nbib Format: NLM
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy.

Frontiers in immunology

Muntasell A, Cabo M, Servitja S, Tusquets I, Martínez-García M, Rovira A, Rojo F, Albanell J, López-Botet M.
PMID: 29181007
Front Immunol. 2017 Nov 13;8:1544. doi: 10.3389/fimmu.2017.01544. eCollection 2017.

Overexpression of the human epidermal growth factor receptor 2 (HER2) defines a subgroup of breast tumors with aggressive behavior. The addition of HER2-targeted antibodies (i.e., trastuzumab, pertuzumab) to chemotherapy significantly improves relapse-free and overall survival in patients with early-stage...

Cite
Muntasell A, Cabo M, Servitja S, et al. Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy. Front Immunol. 2017;8:1544doi: 10.3389/fimmu.2017.01544.
Muntasell, A., Cabo, M., Servitja, S., Tusquets, I., Martínez-García, M., Rovira, A., Rojo, F., Albanell, J., & López-Botet, M. (2017). Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy. Frontiers in immunology, 81544. https://doi.org/10.3389/fimmu.2017.01544
Muntasell, Aura, et al. "Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy." Frontiers in immunology vol. 8 (2017): 1544. doi: https://doi.org/10.3389/fimmu.2017.01544
Muntasell A, Cabo M, Servitja S, Tusquets I, Martínez-García M, Rovira A, Rojo F, Albanell J, López-Botet M. Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy. Front Immunol. 2017 Nov 13;8:1544. doi: 10.3389/fimmu.2017.01544. eCollection 2017. PMID: 29181007; PMCID: PMC5694168.
Copy Download .nbib Format: NLM
The .

Frontiers in oncology

Cuyàs E, Buxó M, Ferri Iglesias MJ, Verdura S, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Joven J, Brunet J, López-Bonet E, Garcia M, Saidani S, Queralt Moles X, Martin-Castillo B, Menendez JA.
PMID: 30984619
Front Oncol. 2019 Mar 28;9:193. doi: 10.3389/fonc.2019.00193. eCollection 2019.

No abstract available.

Cite
Cuyàs E, Buxó M, Ferri Iglesias MJ, et al. The . Front Oncol. 2019;9:193doi: 10.3389/fonc.2019.00193.
Cuyàs, E., Buxó, M., Ferri Iglesias, M. J., Verdura, S., Pernas, S., Dorca, J., Álvarez, I., Martínez, S., Pérez-Garcia, J. M., Batista-López, N., Rodríguez-Sánchez, C. A., Amillano, K., Domínguez, S., Luque, M., Morilla, I., Stradella, A., Viñas, G., Cortés, J., Joven, J., Brunet, J., López-Bonet, E., Garcia, M., Saidani, S., Queralt Moles, X., Martin-Castillo, B., & Menendez, J. A. (2019). The . Frontiers in oncology, 9193. https://doi.org/10.3389/fonc.2019.00193
Cuyàs, Elisabet, et al. "The ." Frontiers in oncology vol. 9 (2019): 193. doi: https://doi.org/10.3389/fonc.2019.00193
Cuyàs E, Buxó M, Ferri Iglesias MJ, Verdura S, Pernas S, Dorca J, Álvarez I, Martínez S, Pérez-Garcia JM, Batista-López N, Rodríguez-Sánchez CA, Amillano K, Domínguez S, Luque M, Morilla I, Stradella A, Viñas G, Cortés J, Joven J, Brunet J, López-Bonet E, Garcia M, Saidani S, Queralt Moles X, Martin-Castillo B, Menendez JA. The . Front Oncol. 2019 Mar 28;9:193. doi: 10.3389/fonc.2019.00193. eCollection 2019. PMID: 30984619; PMCID: PMC6447648.
Copy Download .nbib Format: NLM
Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer.

Oncoimmunology

Hardy-Werbin M, Rocha P, Arpi O, Taus Á, Nonell L, Durán X, Villanueva X, Joseph-Pietras D, Nolan L, Danson S, Griffiths R, Lopez-Botet M, Rovira A, Albanell J, Ottensmeier C, Arriola E.
PMID: 31069160
Oncoimmunology. 2019 Mar 27;8(6):e1593810. doi: 10.1080/2162402X.2019.1593810. eCollection 2019.

No abstract available.

Cite
Hardy-Werbin M, Rocha P, Arpi O, et al. Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. Oncoimmunology. 2019;8(6):e1593810doi: 10.1080/2162402X.2019.1593810.
Hardy-Werbin, M., Rocha, P., Arpi, O., Taus, �. �., Nonell, L., Durán, X., Villanueva, X., Joseph-Pietras, D., Nolan, L., Danson, S., Griffiths, R., Lopez-Botet, M., Rovira, A., Albanell, J., Ottensmeier, C., & Arriola, E. (2019). Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. Oncoimmunology, 8(6), e1593810. https://doi.org/10.1080/2162402X.2019.1593810
Hardy-Werbin, Max, et al. "Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer." Oncoimmunology vol. 8,6 (2019): e1593810. doi: https://doi.org/10.1080/2162402X.2019.1593810
Hardy-Werbin M, Rocha P, Arpi O, Taus Á, Nonell L, Durán X, Villanueva X, Joseph-Pietras D, Nolan L, Danson S, Griffiths R, Lopez-Botet M, Rovira A, Albanell J, Ottensmeier C, Arriola E. Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. Oncoimmunology. 2019 Mar 27;8(6):e1593810. doi: 10.1080/2162402X.2019.1593810. eCollection 2019. PMID: 31069160; PMCID: PMC6492977.
Copy Download .nbib Format: NLM
Changes in .

Animals : an open access journal from MDPI

Benítez R, Núñez Y, Ayuso M, Isabel B, Fernández-Barroso MA, De Mercado E, Gómez-Izquierdo E, García-Casco JM, López-Bote C, Óvilo C.
PMID: 34944282
Animals (Basel). 2021 Dec 08;11(12). doi: 10.3390/ani11123505.

This experiment was conducted to investigate the effects of developmental stage, breed, and diet energy source on the genome-wide expression, meat quality traits, and tissue composition of

Cite
Benítez R, Núñez Y, Ayuso M, et al. Changes in . Animals (Basel). 2021;11(12)doi: 10.3390/ani11123505.
Benítez, R., Núñez, Y., Ayuso, M., Isabel, B., Fernández-Barroso, M. A., De Mercado, E., Gómez-Izquierdo, E., García-Casco, J. M., López-Bote, C., & Óvilo, C. (2021). Changes in . Animals : an open access journal from MDPI, 11(12), . https://doi.org/10.3390/ani11123505
Benítez, Rita, et al. "Changes in ." Animals : an open access journal from MDPI vol. 11,12 (2021). doi: https://doi.org/10.3390/ani11123505
Benítez R, Núñez Y, Ayuso M, Isabel B, Fernández-Barroso MA, De Mercado E, Gómez-Izquierdo E, García-Casco JM, López-Bote C, Óvilo C. Changes in . Animals (Basel). 2021 Dec 08;11(12). doi: 10.3390/ani11123505. PMID: 34944282.
Copy Download .nbib Format: NLM
Free-Range Feeding Alters Fatty Acid Composition at the .

Animals : an open access journal from MDPI

Segura J, Rey AI, Olivares Á, Cambero MI, Escudero R, Ávila MDR, Palomo A, López-Bote C.
PMID: 34679824
Animals (Basel). 2021 Sep 26;11(10). doi: 10.3390/ani11102802.

The nutritional value of fat consumption depends on both the fatty acid composition and the positional distribution of fatty acids within the triglyceride molecule. This research studies the effect of feeding with three different diets (4% lard-enriched; 11.5% high-oleic...

Cite
Segura J, Rey AI, Olivares Á, et al. Free-Range Feeding Alters Fatty Acid Composition at the . Animals (Basel). 2021;11(10)doi: 10.3390/ani11102802.
Segura, J., Rey, A. I., Olivares, �. �., Cambero, M. I., Escudero, R., Ávila, M. D. R., Palomo, A., & López-Bote, C. (2021). Free-Range Feeding Alters Fatty Acid Composition at the . Animals : an open access journal from MDPI, 11(10), . https://doi.org/10.3390/ani11102802
Segura, José, et al. "Free-Range Feeding Alters Fatty Acid Composition at the ." Animals : an open access journal from MDPI vol. 11,10 (2021). doi: https://doi.org/10.3390/ani11102802
Segura J, Rey AI, Olivares Á, Cambero MI, Escudero R, Ávila MDR, Palomo A, López-Bote C. Free-Range Feeding Alters Fatty Acid Composition at the . Animals (Basel). 2021 Sep 26;11(10). doi: 10.3390/ani11102802. PMID: 34679824; PMCID: PMC8532750.
Copy Download .nbib Format: NLM
Effect of dietary selenium source (organic vs. mineral) and muscle pH on meat quality characteristics of pigs.

Food science & nutrition

Calvo L, Toldrá F, Rodríguez AI, López-Bote C, Rey AI.
PMID: 28070320
Food Sci Nutr. 2016 Jun 01;5(1):94-102. doi: 10.1002/fsn3.368. eCollection 2017 Jan.

This study evaluates the effect of organic (Se-enriched yeast; SeY) versus inorganic selenium (sodium selenite; SeS) supplementation and the different response of selenium source according to muscle pH on pork meat quality characteristics. Pigs (

Cite
Calvo L, Toldrá F, Rodríguez AI, et al. Effect of dietary selenium source (organic vs. mineral) and muscle pH on meat quality characteristics of pigs. Food Sci Nutr. 2016;5(1):94-102doi: 10.1002/fsn3.368.
Calvo, L., Toldrá, F., Rodríguez, A. I., López-Bote, C., & Rey, A. I. (2017). Effect of dietary selenium source (organic vs. mineral) and muscle pH on meat quality characteristics of pigs. Food science & nutrition, 5(1), 94-102. https://doi.org/10.1002/fsn3.368
Calvo, Luis, et al. "Effect of dietary selenium source (organic vs. mineral) and muscle pH on meat quality characteristics of pigs." Food science & nutrition vol. 5,1 (2017): 94-102. doi: https://doi.org/10.1002/fsn3.368
Calvo L, Toldrá F, Rodríguez AI, López-Bote C, Rey AI. Effect of dietary selenium source (organic vs. mineral) and muscle pH on meat quality characteristics of pigs. Food Sci Nutr. 2016 Jun 01;5(1):94-102. doi: 10.1002/fsn3.368. eCollection 2017 Jan. PMID: 28070320; PMCID: PMC5217912.
Copy Download .nbib Format: NLM
Intraoperative radiotherapy with electrons: fundamentals, results, and innovation.

Ecancermedicalscience

Calvo F, Sole C, Herranz R, Lopez-Bote M, Pascau J, Santos A, Muñoz-Calero A, Ferrer C, Garcia-Sabrido J.
PMID: 24009641
Ecancermedicalscience. 2013 Aug 15;7:339. doi: 10.3332/ecancer.2013.339. eCollection 2013.

RATIONALE AND OBJECTIVES: To analyse the programme activity and clinical innovation and/or technology developed over a period of 17 years with regard to the introduction and the use of intraoperative radiotherapy (IORT) as a therapeutic component in a medical-surgical...

Cite
Calvo F, Sole C, Herranz R, et al. Intraoperative radiotherapy with electrons: fundamentals, results, and innovation. Ecancermedicalscience. 2013;7:339doi: 10.3332/ecancer.2013.339.
Calvo, F., Sole, C., Herranz, R., Lopez-Bote, M., Pascau, J., Santos, A., Muñoz-Calero, A., Ferrer, C., & Garcia-Sabrido, J. (2013). Intraoperative radiotherapy with electrons: fundamentals, results, and innovation. Ecancermedicalscience, 7339. https://doi.org/10.3332/ecancer.2013.339
Calvo, Fa, et al. "Intraoperative radiotherapy with electrons: fundamentals, results, and innovation." Ecancermedicalscience vol. 7 (2013): 339. doi: https://doi.org/10.3332/ecancer.2013.339
Calvo F, Sole C, Herranz R, Lopez-Bote M, Pascau J, Santos A, Muñoz-Calero A, Ferrer C, Garcia-Sabrido J. Intraoperative radiotherapy with electrons: fundamentals, results, and innovation. Ecancermedicalscience. 2013 Aug 15;7:339. doi: 10.3332/ecancer.2013.339. eCollection 2013. PMID: 24009641; PMCID: PMC3757959.
Copy Download .nbib Format: NLM
NK receptors: tools for a polyvalent cell family.

Frontiers in immunology

Sivori S, Olive D, López-Botet M, Vitale M.
PMID: 25520722
Front Immunol. 2014 Dec 03;5:617. doi: 10.3389/fimmu.2014.00617. eCollection 2014.

No abstract available.

Cite
Sivori S, Olive D, López-Botet M, et al. NK receptors: tools for a polyvalent cell family. Front Immunol. 2014;5:617doi: 10.3389/fimmu.2014.00617.
Sivori, S., Olive, D., López-Botet, M., & Vitale, M. (2014). NK receptors: tools for a polyvalent cell family. Frontiers in immunology, 5617. https://doi.org/10.3389/fimmu.2014.00617
Sivori, Simona, et al. "NK receptors: tools for a polyvalent cell family." Frontiers in immunology vol. 5 (2014): 617. doi: https://doi.org/10.3389/fimmu.2014.00617
Sivori S, Olive D, López-Botet M, Vitale M. NK receptors: tools for a polyvalent cell family. Front Immunol. 2014 Dec 03;5:617. doi: 10.3389/fimmu.2014.00617. eCollection 2014. PMID: 25520722; PMCID: PMC4253963.
Copy Download .nbib Format: NLM
Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona.

International journal of environmental research and public health

Sanvisens A, Puigdemont M, Rubió-Casadevall J, Vidal-Vila A, López-Bonet E, Martín-Romero F, Marcos-Gragera R.
PMID: 34948878
Int J Environ Res Public Health. 2021 Dec 16;18(24). doi: 10.3390/ijerph182413269.

INTRODUCTION: The recent COVID-19 pandemic has compromised socio-health care, with consequences for the diagnosis and follow-up of other pathologies. The aim of this study was to evaluate the impact of COVID-19 on cancer diagnosis in Girona, Spain.METHODOLOGY: Observational study...

Cite
Sanvisens A, Puigdemont M, Rubió-Casadevall J, et al. Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona. Int J Environ Res Public Health. 2021;18(24)doi: 10.3390/ijerph182413269.
Sanvisens, A., Puigdemont, M., Rubió-Casadevall, J., Vidal-Vila, A., López-Bonet, E., Martín-Romero, F., & Marcos-Gragera, R. (2021). Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona. International journal of environmental research and public health, 18(24), . https://doi.org/10.3390/ijerph182413269
Sanvisens, Arantza, et al. "Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona." International journal of environmental research and public health vol. 18,24 (2021). doi: https://doi.org/10.3390/ijerph182413269
Sanvisens A, Puigdemont M, Rubió-Casadevall J, Vidal-Vila A, López-Bonet E, Martín-Romero F, Marcos-Gragera R. Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona. Int J Environ Res Public Health. 2021 Dec 16;18(24). doi: 10.3390/ijerph182413269. PMID: 34948878.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 32 entries